Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C B Eap

Showing results (91-100 of 95) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 95 results.
Clinical Pharmacology and Therapeutics|February 20, 2009
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individualsM Arab-Alameddine, J Di Iulio, T Buclin, et al.
Journal of Clinical Psychopharmacology|March 29, 2001
Cytochrome P450 2D6 genotype and methadone steady-state concentrationsC B Eap, F Broly, A Mino, et al.
The Pharmacogenomics Journal|December 9, 2015
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantationL Quteineh, P-Y Bochud, D Golshayan, et al.
Molecular Psychiatry|August 5, 2015
The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbensD Y Sakae, F Marti, S Lecca, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 12, 2021
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressantsC B Eap, G Gründer, P Baumann, et al.
Pageof 10

Showing results (91-100 of 95) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 95 results.
Clinical Pharmacology and Therapeutics|February 20, 2009
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individualsM Arab-Alameddine, J Di Iulio, T Buclin, et al.
Journal of Clinical Psychopharmacology|March 29, 2001
Cytochrome P450 2D6 genotype and methadone steady-state concentrationsC B Eap, F Broly, A Mino, et al.
The Pharmacogenomics Journal|December 9, 2015
CRTC2 polymorphism as a risk factor for the incidence of metabolic syndrome in patients with solid organ transplantationL Quteineh, P-Y Bochud, D Golshayan, et al.
Molecular Psychiatry|August 5, 2015
The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbensD Y Sakae, F Marti, S Lecca, et al.
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|May 12, 2021
Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressantsC B Eap, G Gründer, P Baumann, et al.
Pageof 10